MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $909,245 | -39.7% | 6,226 | -4.6% | 0.00% | -33.3% |
| Q2 2023 | $1,507,737 | -6.8% | 6,527 | -2.3% | 0.00% | -25.0% |
| Q1 2023 | $1,618,539 | +195.8% | 6,681 | +254.4% | 0.00% | +300.0% |
| Q4 2022 | $547,121 | -2.1% | 1,885 | -62.0% | 0.00% | 0.0% |
| Q4 2018 | $559,000 | -62.9% | 4,955 | -29.6% | 0.00% | 0.0% |
| Q3 2018 | $1,508,000 | -54.3% | 7,041 | -40.3% | 0.00% | -66.7% |
| Q2 2018 | $3,298,000 | +392.2% | 11,790 | +105.5% | 0.00% | +200.0% |
| Q1 2018 | $670,000 | – | 5,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |